iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDD – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 29,702 shares, a growth of 128.0% from the August 15th total of 13,027 shares. Based on an average trading volume of 14,450 shares, the short-interest ratio is presently 2.1 days. Currently, 1.1% of the shares of the company are sold short.
iShares LifePath Target Date 2040 ETF Stock Performance
Shares of NYSEARCA:ITDD opened at $38.80 on Monday. The firm has a market capitalization of $105.54 million, a PE ratio of 20.77 and a beta of 0.73. iShares LifePath Target Date 2040 ETF has a 1-year low of $34.08 and a 1-year high of $39.47. The business’s 50 day moving average is $38.75 and its 200-day moving average is $37.62.
Institutional Investors Weigh In On iShares LifePath Target Date 2040 ETF
A number of institutional investors have recently bought and sold shares of the business. Sunbelt Securities Inc. bought a new position in shares of iShares LifePath Target Date 2040 ETF during the 3rd quarter worth approximately $79,000. Bellwether Advisors LLC bought a new stake in iShares LifePath Target Date 2040 ETF in the fourth quarter valued at $249,000. Finally, Jane Street Group LLC acquired a new position in iShares LifePath Target Date 2040 ETF during the fourth quarter worth $638,000.
About iShares LifePath Target Date 2040 ETF
The iShares LifePath Target Date 2040 ETF (ITDD) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2040 ITDD was launched on Oct 17, 2023 and is issued by BlackRock.
Further Reading
- Five stocks we like better than iShares LifePath Target Date 2040 ETF
- Smart Money Shifts: U.S. Bancorp Pairs Tech With Yield
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
Receive News & Ratings for iShares LifePath Target Date 2040 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2040 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
